MRLF-DDI:用于药物相互作用事件预测的多视图表示学习框架
IEEE journal of biomedical and health informatics
|July 24, 2025
概括
预测药物相互作用事件 (DDIEs) 对药物安全至关重要. 我们的新框架MRLF-DDI使用先进的图形神经网络和几何意识功能来提高预测准确性,特别是在新药方面.
科学领域:
- 药理学和化学信息学
- 人工智能在医学中的应用
- 计算机化药物发现技术
背景情况:
- 准确预测药物相互作用事件 (DDIEs) 对于患者安全和有效的临床实践至关重要.
- 目前的图形神经网络 (GNN) 方法在整合各种药物特征和将其推广到新药或未经研究的药物方面面临挑战.
- 现有模型的局限性阻碍了对复杂药物相互作用的全面理解和预测.
研究的目的:
- 开发一个先进的多视图表示学习框架 (MRLF-DDI) 以提高DDIE预测.
- 在一个统一的模型中整合单个药物特征,本地相互作用背景和全球相互作用模式.
- 在DDIE预测中引入新的几何意识特征,包括原子级结构和结合角度信息.
主要方法:
- 拟议的MRLF-DDI框架包含多视图表示学习.
- 利用了原子级结构特征,并提供了结合角度信息,以增强几何表示.
- 采用多颗粒度的GNN架构和一个封闭的知识传输策略,以改进功能学习和概括.
- 对基准数据集进行了广泛的实验,以评估模型性能.
主要成果:
- 与现有方法相比,MRLF-DDI在热启动和冷启动场景中都表现出优异的性能.
- 该模型有效地整合了多视图药物信息,导致更准确的DDIE预测.
- 案例研究和可视化分析证实了MRLF-DDI在确定临床相关相互作用方面的实用性.
- 整合了几何意识的功能,显著改善了模型概括能力.
结论:
- MRLF-DDI为预测药物相互作用事件提供了强大而有效的解决方案.
- 该框架能够处理多视图特征,并将其泛化为新药,解决了当前方法的关键局限性.
- 几何意识特征的集成代表了计算DDIE预测领域的重大进步.
- 通过改善相互作用预测,MRLF-DDI有望提高药物安全性并指导临床决策.
相关概念视频
Drug-Receptor Interactions
6.0K
Drug-receptor interaction describes the binding of receptors by drugs, but not all drug-receptor interactions result in activation and tissue response. For instance, the binding of agonists activates the receptor to generate a cellular reaction, while antagonists bind to receptors without causing their activation.
Several parameters, such as the drug's affinity for its receptor and its efficacy, which is its ability to activate the receptor, determine the drug's effect on the tissue....
Several parameters, such as the drug's affinity for its receptor and its efficacy, which is its ability to activate the receptor, determine the drug's effect on the tissue....
6.0K
Combined Effects of Drugs: Synergism
4.8K
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
Such synergistic combinations...
4.8K
Quantitative Aspects of Drug-Receptor Interaction
1.2K
The receptor occupancy theory connects a drug's response to the number of occupied receptors. With higher drug concentrations, more receptors are occupied, leading to increased responses. The formation of drug-receptor complexes involves association and dissociation rates, which reach equilibrium when the forward and backward reactions are equal. The equilibrium association constant (Ka) and its inverse, the equilibrium dissociation constant (Kd), indicate drug affinity. Higher Ka and lower...
1.2K
Drug-Receptor Interaction: Antagonist
3.5K
An antagonist is a drug that binds strongly to a receptor without activating it. An antagonist prevents other molecules, such as neurotransmitters or hormones, from binding to the receptor and triggering a cellular response. Such interaction effectively hinders the normal physiological processes mediated by the receptor, resulting in various pharmacological effects depending on the specific receptor targeted.
Antagonists can be classified as competitive or noncompetitive based on their...
Antagonists can be classified as competitive or noncompetitive based on their...
3.5K
Combined Effects of Drugs: Antagonism
9.3K
The combined effects of drugs can result in various interactions, of which an important type is antagonism. Antagonism is a mechanism where one drug inhibits or counteracts the effects of another drug. Antagonism can occur through various means, including receptor binding, allosteric modulation, functional interaction, chemical reactions, and pharmacokinetic processes.
The most common type is receptor antagonism, where one drug acts as an antagonist to block the effects of another drug by...
The most common type is receptor antagonism, where one drug acts as an antagonist to block the effects of another drug by...
9.3K
Drug-Receptor Interaction: Agonist
2.8K
Agonists are drugs that interact with specific receptors in the body to produce a biological response. When an agonist binds to a receptor, it activates or enhances the receptor's function, leading to physiological effects. The interaction between agonist drugs and receptors is crucial for their therapeutic action in various medical treatments.
Agonists can bind to receptors in different ways. Some agonists bind directly to the receptor's active site, mimicking the endogenous...
Agonists can bind to receptors in different ways. Some agonists bind directly to the receptor's active site, mimicking the endogenous...
2.8K


